Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis.

Centro de Biotecnologia, Universidade Federal de Pelotas, Pelotas, Brazil.
Canadian Journal of Microbiology (Impact Factor: 1.2). 05/2007; 53(4):472-9. DOI: 10.1139/w06-138
Source: PubMed

ABSTRACT Leptospirosis, caused by bacteria of the genus Leptospira, is a direct zoonosis with wide geographical distribution. The implications in terms of public health and the economical losses caused by leptospirosis justify the use of a vaccine against Leptospira in human or animal populations at risk. In this study, we used the external membrane protein LipL32 as a model antigen, as it is highly immunogenic. The LipL32 coding sequence was cloned into several expression vectors: (i) pTarget, to create a DNA vaccine; (ii) pUS973, pUS974, and pUS977 for expression in BCG (rBCG); and (iii) pAE, to express the recombinant protein in Escherichia coli, for a subunit vaccine. Mice were immunized with the various constructs, and the immune response was evaluated. The highest humoral immune response was elicited by the subunit vaccine (rLipL32). However, with rBCG, the titer was still rising at the end of the experiment. The serum of vaccinated animals was able to recognize LipL32 on the membrane of the Leptospira, detected by indirect immunofluorescence. A monoclonal antibody anti-LipL32 was shown to inhibit the growth of Leptospira in vitro, indicating potential protection induced by the LipL32 antigen.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Leptospira interrogans vaccines currently available are serovar specific and require regular boosters to maintain protection of the host. In addition a hamster challenge batch potency test is necessary to evaluate these vaccines prior to market release, requiring the use of a large number of animals which is ethically and financially undesirable. Our previous work identified that the N terminus of the outer membrane protein LipL32 was altered in serovar Canicola vaccines that fail the hamster challenge test, suggesting that it may be involved in the protective immune response. The aim of this study was to determine if vaccination with LipL32 protein alone could provide a protective response against challenge with serovar Canicola to hamsters. Recombinant LipL32, purified from an E. coli expression system, was assessed for protective immunity in five groups of hamsters (n=5) following challenge with the virulent Leptospira interrogans serovar Canicola strain Kito as a challenge strain. However no significant survival against serovar Canicola challenge was observed compared to unvaccinated negative controls. Subsequent histological analysis revealed reduced numbers of L. interrogans in kidneys from hamsters vaccinated with recombinant LipL32 protein prior to challenge; however no significant survival against serovar Canicola challenge was observed compared to unvaccinated negative controls. This finding corresponded to a noticeably reduced severity of renal lesions. This study provides evidence that LipL32 is involved in the protective response against serovar Canicola in hamsters and is the first reported link to LipL32 induced protection against kidney invasion.
    Clinical and vaccine Immunology: CVI 02/2014; · 2.60 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Spirochetal diseases such as syphilis, Lyme disease, and leptospirosis are major threats to public health. However, the immunopathogenesis of these diseases has not been fully elucidated. Spirochetes interact with the host through various structural components such as lipopolysaccharides (LPS), surface lipoproteins, and glycolipids. Although spirochetal antigens such as LPS and glycolipids may contribute to the inflammatory response during spirochetal infections, spirochetes such as Treponema pallidum and Borrelia burgdorferi lack LPS. Lipoproteins are most abundant proteins that are expressed in all spirochetes and often determine how spirochetes interact with their environment. Lipoproteins are pro-inflammatory, may regulate responses from both innate and adaptive immunity and enable the spirochetes to adhere to the host or the tick midgut or to evade the immune system. However, most of the spirochetal lipoproteins have unknown function. Herein, the immunomodulatory effects of spirochetal lipoproteins are reviewed and are grouped into two main categories: effects related to immune evasion and effects related to immune activation. Understanding lipoprotein-induced immunomodulation will aid in elucidating innate immunopathogenesis processes and subsequent adaptive mechanisms potentially relevant to spirochetal disease vaccine development and to inflammatory events associated with spirochetal diseases.
    Frontiers in Immunology 01/2014; 5:310.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Over 230 serovars of Leptospira interrogans have been identified; however few have been completely characterised. The aim of this study was to characterise the proteome of serovar Canicola and to compare this against the serovars of Copenhageni and Pomona. 2D-LC/MS analysis identified 1653 Leptospira proteins in serovar Canicola; 60 of these proteins were common to Copenhageni and Pomona, 16 of which are known to be immunogenic. This study provides the first reported proteome for serovar Canicola and suggests that proteomic comparison of different serovars could be used as a tool for identification of novel target molecules for vaccine development.
    International journal of proteomics. 01/2014; 2014:572901.


Available from
May 29, 2014